Photodynamic Therapy Market, By Indication, By End User, By Photosensitizer Type, By Application, By Treatment Type, By Light Source, By Patient Type, By Distribution Channel, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
Photodynamic therapy uses light-sensitive medicine and a special light source to destroy cancerous or precancerous cells. This treatment limits damage to surrounding healthy tissue. You’ll receive the photosensitizer by mouth, injection or through an IV, depending on the area being treated. Then the doctor exposes the area to special light.
Market Dynamics:
Increasing incidence of cancer and skin disorders, minimally invasive treatment demand, and advancements in technology is anticipated to drive growth of the global photodynamic therapy market over the forecast period. Moreover, favorable regulatory approvals is also expected to boost the growth of the global photodynamic therapy market over the forecast period. Personalized treatment approaches, collaboration with pharmaceutical companies, advancements in imaging techniques, and telemedicine and remote consultations are expected to create growth opportunities for the global photodynamic therapy market during the forecast period.
However, limited awareness and education, high treatment costs, and complex treatment protocols are expected to hamper growth of the photodynamic therapy market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global photodynamic therapy market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global photodynamic therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Biofrontera AG, Theralase Technologies Inc., Photocure ASA, Quest PharmaTech Inc., Galderma S.A., DUSA Pharmaceuticals (a subsidiary of Sun Pharmaceutical Industries), Lumenis Ltd. (acquired by Bausch Health Companies Inc.), Biolitec AG, IPG Photonics Corporation, Boston Scientific Corporation, Asieris Meditech Co., Ltd., PDT Pharmaceuticals, Inc., Candela Corporation (a subsidiary of Syneron Medical Ltd.), Biolase, Inc., Photothera (now known as EpiCept Corporation)
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global photodynamic therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global photodynamic therapy market
Detailed Segmentation:
Global Photodynamic Therapy market, By Indication:
Cancer (Skin cancer, Lung cancer, Brain cancer, etc.)